Alaven Pharmaceuticals

Management Profiles

Bala Venkataraman, CEO

William Campbell, VP, CFO

Connie Swanson, VP, Sales and Marketing

Virinder Nohria, Chief Medical Officer

Dan Gunderson, Director of Sales

Patricia Conary, Director of Marketing, OTC Division

Jai Wall, Director of Marketing, Rx Division

Bala Venkataraman was previously Chief Operating Officer (2002- 2003), Chief Financial Officer (1999- 2002), VP Business Development, Strategic Planning and Operations (1998 -2000) at First Horizon Pharmaceutical Corporation. Bala was responsible for growing the company from an operating loss and sales of approximately $5M, to, at its peak, an operating profit of approximately $14M and sales of approximately $115M in 5 years. In addition, Bala was responsible for in-licensing or acquiring over 15 drugs, commercializing 8 products, concluding 5 co-promotion agreements, and developing the company’s product pipeline through partnerships with contract manufacturers, research organizations and drug development companies. He successfully took the company public and raised in excess of $500M in debt and equity capital, and built the company employee base from approximately 70 people to approximately 300 people. Bala’s previous experiences includes: venture capitalist in managing specialty pharmaceutical and biotechnology investments for EJ Financial (Neopharm, First Horizon Pharmaceutical, ProtoMed), product management at Schering Plough (oncology drug Intron^®A), Licensing and New Business Start-up, at the University of Pennsylvania Center for Technology Transfer, Marketing Manager at Curative Technologies Inc. (marketing of wound care services and launch of autologous growth factor Procuren^®), Technical Sales Representative for Millipore Corporation (purification equipments to pharmaceutical companies), Senior Research Chemist at Scios Inc (cardiovascular and inflammation product development). Bala has an M.S. degree in Organic Chemistry from Case Western Reserve University and an M.B.A. degree from the Wharton School of Business. Bala has several research publications and holds two patents and has several patent applications pending. He is a member of the Licensing Executives Society.

William (Bill) Campbell was previously Controller (1998 - 2003), Treasurer (1999 - 2003) and VP of Administration (2002 - 2003) at First Horizon Pharmaceutical Corporation. At First Horizon, Bill was responsible for all aspects of the finance function, including inventory management, budgeting, managing the cash flow, product acquisition, debt and equity financing, operationalizing the sales force and managing human resources. Bill was critical in making the company profitable and successfully sustaining the profits, completing a successful IPO with limited equity financing prior to the IPO, helping raise over $350M in equity and $150M in debt, managing over 50 operating agreements, managing 12 manufacturers and over 40 product SKUs and operating the company under high leverages. Prior to joining First Horizon, from 1995 to 1998, Bill was the Controller/Chief Financial Officer of Dialysis America, Inc and was responsible for the successful and profitable sale of the company to Fresinius. He was the Associate Administrator/Chief Financial Officer of Stringfellow Memorial Hospital from 1993 to 1995, and from 1989 to 1993, he was the Director of Budgets, Costs and Reimbursement at Grady Memorial Hospital. His prior professional experience also includes a number of for-profit and not-for-profit consulting, big four public accounting, governmental auditing and internal audit positions. Bill is a Certified Public Accountant and received a B.A. degree in Accounting from Walsh College of Accountancy and Business Administration and an M.B.A. degree in Accounting from Kennesaw State College.

Connie Swanson was previously Senior Director of Marketing (1999 - 2001) and National Sales Trainer (1996 - 1999) at First Horizon Pharmaceutical Corporation. Connie was responsible for hiring, training, deploying and successfully managing a significant majority of the First Horizon sales force and sales management during several sales force expansions prior to 2001. In addition, as head of Marketing, Connie launched several of First Horizon’s key brands including Ponstel^® (Women’s Health), Zebutal^® (Tension Headache), Nitrolingual Pumpspray^® (Cardiology), Robinul^® (Gastroenterology) and Tanafed^® (Pediatric) while managing a team of product managers. Connie was also instrumental in the selection and acquisition of three of First Horizon’s key products, Robinul^®, Ponstel^® and Nitrolingual^® Pumpspray. Connie was the Company’s top producing sales representative and district manager during its formative years (1993 - 1995). Connie earned a B.S. degree in Chemistry from North Georgia College and State University and worked as a pharmacy technician while obtaining her degree.

Virinder Nohria was previously the Chief Medical Officer of Xcel Pharmaceutical (2004-2005) and Chief Medical Officer of DevCo Pharmaceutical (1999-2003). He was a Senior Research Physician for UCB Pharma and Global Physician, Neurology Division, for Eli Lilly and Company. Dr. Nohria was responsible for the development and approval of Keppra^® and Permax^®. He was also part of the team that was responsible for the development and approval of Zyprexa^®. Dr Nohria has eight years of clinical practice in the area of pediatric neurology in both the United Kingdom and the United States. Dr. Nohria was an Assistant Professor of Pediatrics and Neurology at University of Virginia and is currently an Assistant Professor at the Emory School of Medicine. He earned his medical degree at Cambridge University and his Ph.D. at Leeds University.

Dan Gunderson was previously Regional Account Manager (2002-2003), District Manager (1998-2002), Managed Care Director (1997-1998) and National Field Sales Trainer (1997) at First Horizon Pharmaceutical Corporation. At First Horizon, Dan was most recently responsible for all Managed Care Accounts and Medicaid contracts for the Midwest and Southeast. Throughout Dan’s tenure other responsibilities included classroom and field training of new representatives, starting the Managed Care Department, managing districts in the West, Southwest, Midwest and Southeast. First Horizon expanded its sales force 6 times during Dan’s Sales Management responsibilities. Prior to joining First Horizon, Dan was employed by Central Pharmaceuticals/Schwarz Pharma AG (1990-1996). Dan started in the pharmaceutical industry with Central as a Territory Manager. Other positions held were District Supervisor, Managed Care Coordinator and District Manager. Dan is a current active member of the Academy of Managed Care Pharmacy. He holds a BS degree in Marketing from the University of Wisconsin-LaCrosse with an emphasis in Management.

Patricia Conary was previously at UCB, Inc. in Marketing Research and Brand Management , working in therapeutic areas including biologics (CIMZIA™), dermatology (Olux™ and Luxiq™), CNS (FROVA™)and ADHD (Metadate CD™). As President of PS Communications, Inc., a marketing consultation firm, her clients included Allergan, Kimberly-Clark, CIBA/Novartis, Santen Pharmaceuticals, and the American Cancer Society. She spent 6 years at CIBA Vision, and as the Group Director of Marketing she was responsible for the launch of CIBA’s first contact lenses, CIBASoft® and CIBAThin®, their first lens care product, and the first cosmetic soft contact lens marketed directly to consumers, SoftColors®, which achieved $50 million in sales the first year. She also spent 5 years with Bausch & Lomb, Inc. in ophthalmic sales. Patty has a B.A. in Economics from the State University of NY at Geneseo.

Jai Wall was previously Senior Product Manager, Gastroenterology (2003 – 2007), Corporate Development Advisor (2001 - 2002) and Senior Manager, Contracting and Sales Services (1999 – 2000) at Solvay Pharmaceuticals, Inc. As Product Manager at Solvay, Jai was responsible for leading the sales and marketing team which halted and reversed the declining sales trend of Creon^® Minimicrospheres^® leading to a doubling of sales in three years. In addition, while expatriated to Belgium, Jai worked with the Executive Committee of Solvay S.A. on corporate strategy issues including M&A projects and long term planning. Prior to Solvay, Jai was with Abbott Laboratories, Inc. (1990 – 1999), Glaxo, Inc (1989) and ZS Associates (1984 – 1987) in a variety of positions including Strategic Pricing, Sales Representative, Market Research Intern and Analyst. Jai has a degree in Industrial Engineering from Northwestern University and a M.B.A from Duke University.